Der er kun sjældent rapporteret om rhabdomyolyse, hvilket dog bliver mere udtalt, når proteasehæmmerne administreres sammen med nukleosidanaloger.
Rhabdomyolysis: an increase in CPK, myalgia, myositis, and rarely, rhabdomyolysis, have been reported with protease inhibitors, more specifically in association with nucleoside analogues.